Chronic psychosocial and financial burden accelerates 5-year telomere shortening: findings from the Coronary Artery Risk Development in Young Adults Study. by Cabeza de Baca, Tomás et al.
UCSF
UC San Francisco Previously Published Works
Title
Chronic psychosocial and financial burden accelerates 5-year telomere shortening: findings 
from the Coronary Artery Risk Development in Young Adults Study.
Permalink
https://escholarship.org/uc/item/9n2299dv
Journal
Molecular psychiatry, 25(5)
ISSN
1359-4184
Authors
Cabeza de Baca, Tomás
Prather, Aric A
Lin, Jue
et al.
Publication Date
2020-05-01
DOI
10.1038/s41380-019-0482-5
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Chronic psychosocial and financial burden accelerates 5-year 
telomere shortening: Findings from the Coronary Artery Risk 
Development in Young Adults Study
Tomás Cabeza de Baca, PhD1,a,*, Aric A. Prather, PhD2, Jue Lin, PhD3, Barbara Sternfeld, 
PhD4, Nancy Adler, PhD2, Elissa S. Epel, PhD2, Eli Puterman, PhD5,*
1Division of Cardiology, 400 Parnassus Ave., AC-16, Box 0369, San Francisco, CA 94143, USA, 
University of California, San Francisco
2Department of Psychiatry, University of California San Francisco
3Biochemistry and Biophysics, University of California, San Francisco
4Division of Research, Kaiser Permanente
5School of Kinesiology, University of British Columbia, Vancouver, War Memorial Gymnasium, 
Room 210, 6081 University Boulevard, Vancouver, BC V6T 1Z1
Abstract
Leukocyte telomere length, a marker of immune system function, is sensitive to exposures such as 
psychosocial stressors and health-maintaining behaviors. Past research has determined that stress 
experienced in adulthood is associated with shorter telomere length, but is limited to mostly cross-
sectional reports. We test whether repeated reports of chronic psychosocial and financial burden is 
associated with telomere length change over a 5-year period (Years 15 and 20) from 969 
participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study, a 
longitudinal, population-based cohort, ages 18–30 at time of recruitment in 1985. We further 
examine whether multisystem resiliency, comprised of social connections, health-maintaining 
behaviors, and psychological resources, mitigates the effects of burden on telomere attrition over 
five years. Our results indicate that adults with high chronic burden do not show decreased 
telomere length over the five-year period. However, these effects do vary by level of resiliency, as 
regression results revealed a significant interaction between chronic burden and multisystem 
resiliency. For individuals with high chronic burden and low multisystem resiliency (1SD below 
the mean), there was a significant 5-year shortening in telomere length, whereas no significant 
relationships between chronic burden and attrition were evident for those at moderate and higher 
levels of resiliency. These effects apply similarly across the three components of resiliency. 
Results imply that interventions should focus on establishing strong social connections, 
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psychological resources, and health maintaining behaviors when attempting to ameliorate stress-
related decline in telomere length among at-risk individuals.
Introduction
Exposure to life stressors and the experience of chronic psychological stress have been 
linked to disease development and early mortality.1–4 While engagement in unhealthy 
behaviors account for a portion of how stress increases risk for disease and mortality, 
widespread evidence suggests that prolonged activation of two neurobiological pathways, 
the sympathetic adrenal medullary pathway and the hypothalamic-pituitary-adrenal axis 
disrupts effective regulation of immunity and cellular metabolism.5 Stress-related 
decrements in immune functioning include impaired wound healing, poorer control of latent 
viruses and vaccination responses, and elevated states of chronic inflammation.6 This 
gradual deterioration of the immune system is partly marked and driven by shortened 
telomeres, inflammation and oxidative stress.7,8
Telomeres are DNA-protein complexes at the ends of chromosomes that protect genes from 
degradation and oxidative damage, shortening with each cell division. Animal research 
implicates telomeric shortening in cellular damage and mortality.9,10 Meta-analytic11 and 
Mendelian randomization studies12 implicate shorter telomeres and common sequence 
variants of seven telomere-regulating genes with cardiovascular disease pathogenesis. Meta-
analyses also associate shorter telomeres cross-sectionally with cancer13,14 and type 2 
diabetes.15 Other Mendelian randomization studies associate the telomere-regulating 
common sequence variants with pulmonary16 and Alzheimer’s diseases.17 Majority of 
studies,18–24 with several exceptions,25–28 further indicate that shorter telomeres predict 
mortality.29
Research demonstrates that exposure to life stressors and reported chronic adult 
psychological stress30–35 are associated with shorter telomeres. These studies typically 
examine specific exposures, such as caregiving, unemployment, and domestic violence, or 
reported chronic psychological stress, and their relationships to telomere length. These 
effects were confirmed by a recent systematic review and meta-analysis, demonstrating a 
small and negative correlation between stress and telomere length.36 Emerging evidence 
suggests examining a diversity of exposures to life stressors in adulthood and how they may 
accumulate to predict short telomeres. Puterman and colleagues recently demonstrated that 
major life stressors experienced in adulthood accumulate to predict shorter telomeres in 
nearly 5,000 older adults in a nationally-representative U.S. sample, though these effects 
were non-significant after adjustment for socioeconomic and behavioral factors.37 Others 
have also examined whether stressful life events accumulate to predict shorter telomeres in 
adults, but within shorter time frames. Verhoeven and colleagues38 found that increasing 
numbers of recent stressful life events within the past five years, such as unemployment or 
financial loss were significantly related to shorter telomeres in Dutch adults.
While these studies suggest an association between accumulated adulthood life stressors and 
shorter telomeres, they are retrospective accounts of events and thus unable to prospectively 
establish whether accrual of stressful life events predicts rate of shortening over time. 
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Studies with multiple assessments of telomere length are needed to determine whether 
accumulation of stressful events promote telomere attrition. To date, one study has examined 
this question in adults, and demonstrated that greater accumulation of adverse events over 
the course of a year was significantly associated with accelerated telomere shortening over 
the same period of time.39 The current study examines the relationship between reports of 
chronic psychological and financial burden experienced and the rate of telomere attrition 
over the next five years. Effects were further examined for consistency across race.
Yet, not everyone experiencing chronic burden in adulthood is at equal risk for accelerated 
telomere shortening, specifically, or disease development, generally. Interest exists in 
moderating factors that compound or mitigate the effects of chronic burden on disease 
pathogenesis. While there is considerable focus on genetic polymorphisms that promote 
differential susceptibilities to environmental factors, a long established basis exists for 
examining psychosocial and behavioral resources that mitigate the association between 
chronic stress and telomere attrition. Previous research suggests that psychosocial factors 
may play a role in dampening the association between stress and health. Psychological 
resources, including optimism or mastery,40,41 social connections,42 and health-maintaining 
behaviors,43 have each been shown to mitigate the effects of stress on markers of disease 
pathogenesis, regardless of whether stress is measured as major life events, chronic burden 
in response to certain life domains (as measured in the present study), or general chronic 
psychological stress, as measured by the Perceived Stress Scale.44 Physical activity has also 
been demonstrated to moderate the cross-sectional relationship between chronic 
psychological stress and telomere length45 and to lengthen telomeres in previously inactive 
family caregivers reporting high psychological stress randomized to 6 months of aerobic 
exercise.46
While resiliency factors are typically examined independently, recent work proposes that 
resiliency factors can summate and more effectively mitigate stress effects on health than 
each factor alone.47–49 To illustrate, maintaining a physically active lifestyle, in combination 
with eating and sleeping well, mitigates 1-year telomere attrition associated with adverse life 
experiences.39 The use of a multisystem approach (i.e. summing psychosocial and 
behavioral factors) also moderates the association between depression and shorter telomeres.
50
 Thus, in the current study, the independent and combined associations between 
psychological resources, social connections, and health behaviors with 5-year rate of 
telomere attrition were tested. We further tested whether these factors mitigate prospective 
and longitudinal associations between chronic psychosocial and financial burden and 5-year 
telomere attrition.
Method
Sample
The Coronary Artery Risk Development in Young Adults study (CARDIA; http://
www.cardia.dopm.uab.edu/) examines the development and sociodemographic, behavioral, 
physiological and psychosocial determinants of cardiovascular disease. Data collection 
started in 1985 with 5,115 healthy black and white participants between 18 and 30 years old. 
The original cohort was balanced by race, sex, education, and age (see51 for further 
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recruitment and procedural information). CARDIA currently includes nine examination 
periods: 1985–1986 (baseline), 1987–1988 (Y2), 1990–1991 (Y5), 1992–1993 (Y7), 1995–
1996 (Y10), 2000–2001 (Y15), 2005–2006 (Y20), 2010–2011 (Y25), and 2015–2016 (Y30).
The present study uses Y15 and Y20 data from a CARDIA ancillary study, Socioeconomic 
Status, Stress and Aging. Seventy-two percent and 69% of the original CARDIA cohort 
participated in Y15 and Y20. All participants completed blood draws at each year. 
Participants were selected for the ancillary study if they had stored whole blood available at 
Y15, Y20 and Y25 (all inclusive, N = 2,480) and had completed tests for coronary artery 
calcification at all three years (N = 1,258), participants also had to provide permission to 
utilize blood for DNA studies. A total of 1,002 participants met these criteria and were 
included in the ancillary study. 969 participants had viable DNA for reliable telomere length 
estimation. Participants included in this ancillary study, compared to those not in the 
ancillary, were slightly older at Y15 of CARDIA (40.50 vs 40.06), more likely to be female 
(65.33% vs. 51.97%), white (59.55% vs. 45.84%), have a higher level of education (2.02 
vs.1.96), and were more likely to be non-smokers (18.92% vs 23.14%). non-drinkers 
(27.45% vs. 17.42%) and heavy drinkers (9.29% vs. 5.40%). Participants included did not 
differ in body mass index (kg/m2) or physical activity level from those not included. The 
University of California San Francisco’s institutional review board approved this secondary 
analysis with de-identified data. Only CARDIA study participants who consented to allow 
for the use of their stored biological samples in future genetic or molecular studies were 
included in this study. Table 1 presents the descriptive statistics for the present sample.
Measures
Chronic Burden.—At Y15 and Y20, participants rated whether they were experiencing 
ongoing difficulties lasting ≥6 months across four life domains (health of close others, work, 
financial, and relationships), and if so, whether the experience was stressful. Respondents 
scored each domain on a 4-point scale: ‘1, None’; ‘2, Yes, but not very stressful’; ‘3, Yes, 
moderately stressful’; and ‘4, Yes very stressful’. For each domain, responses ‘1’ and ‘2’ 
were recoded ‘0’ as no or low burden and responses ‘3’ and ‘4’ recoded ‘1’ as moderate or 
high burden, as done previously52. Y15 dichotomized variables across all domains were 
summed for a Y15 chronic burden exposure score, repeated for Y20, and also summed for a 
Repeated Chronic Burden score. The composite for each year of assessment ranged from 0 
to 4, and for the two repeated years was 0 to 8, with higher scores denoting greater exposure 
to chronic psychosocial and financial burden.
Psychological Resources.—Taylor and Seeman40 identified several components of 
psychological resources that are protective from harmful effects of stress exposures, 
including optimism, mastery, and emotional regulation, that, in CARDIA, was assessed at 
Y15 only. These components were assessed, respectively, with the (1) Life Orientation Test-
Revised53 (sample item: “In uncertain times, I usually expect the best”; α = .78; 6-items), 
(2) Pearlin Mastery Scale54 (sample item: “I have little control over the things that happen to 
me”; α = .78; 7 items), and (3) the Reactive Responding Scale40 (sample item: “I often 
respond quickly and emotionally when something happens”; α = .59; 9 items), and. All 
items in all three scales were rated either ‘1, strongly agree’, ‘2, agree’, ‘3, neutral’, ‘4, 
de Baca et al. Page 4
Mol Psychiatry. Author manuscript; available in PMC 2020 May 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
disagree’ or ‘5, strongly disagree’, and all scales were scored such that higher scores 
corresponded to higher levels of the psychological resource. Each scale was then 
standardized and summed for a total psychosocial resources factor. Scores ranged from 
−8.96 to 6.23.
Social connections.—Two combined scales at Y15 were used52 to measure the 
magnitude of participants’ sense of social connection, , rated either ‘1, not at all’, ‘2, a little’, 
‘3, some’, or ‘4, a lot’: family emotional support (α = .82; 4-items) and family demands/
burdens (α = .73; 4-items; reverse-coded). An example item from the family emotional 
support scale is “How much do members of your family or friends really care about you” 
and an example item from the family demands/burdens scale is “How often do members of 
your family or friends make too many demands on you?” Both scales were standardized and 
summed for a total of social connections factor. Higher scores denote a greater sense of 
social-connectedness. Scores ranged from −7.44 to 2.51.
Health-Maintaining Behaviors.—Two health-maintaining behaviors collected at Y15 
were assessed: Sleep quality for the last month and total amount of physical activity over the 
past year. Sleep quality was measured with a 1-item question (“During the past month, how 
would you rate your sleep quality overall?”), on a 5-point scale ranging from (1) very good 
to (5) very bad and reverse-coded and Z-scored. Participants completed the physical 
activities history (PAH) questionnaire that measured the frequency and duration of 13 
categories of moderate (3 to 4 Metabolic Equivalent units; MET) and vigorous physical 
activity (≥ 5 METs) over the previous 12 months. Participants recalled number of months of 
minimal participation in each activity and number of months of specified weekly duration. 
Total amount of physical activity in Exercise Units (EU) was obtained by multiplying 
weighted frequency by intensity of activity and summing over all activities. PAH total scores 
were then standardized and summed with sleep quality score for a total Health-Maintaining 
Behaviors score. Greater values indicate greater engagement in health-maintaining 
behaviors. Scores ranged from −3.49 to 5.90.
Multisystem Resiliency.—Multisystem resiliency was an averaged composite of 
standardized health-maintaining behaviors, social connections, and psychological resources, 
where higher scores denoted greater resiliency. Scores ranged from −9.13 to 5.76. Part-
whole correlations for the composite and its respective components (Table 2) indicate the 
measures were appropriate to composite. The present set of analyses used the individual 
components (psychological resources, social connections, and health-maintaining behaviors) 
and the combined multisystem resiliency score in analyses.
Leukocyte Telomere Length.—Leukocyte telomere length (TL) was obtained via 
banked CARDIA blood samples from years 15 and 20 on 1002 individuals. Specimen were 
shipped in 96 well plates and housed in a freezer at −80°C at the Blackburn laboratory at 
UCSF. Blood samples were thawed on the day of the assay and transferred to 384 well 
plates. The leukocyte TL assay was performed using quantitative PCR methodology adapted 
from Cawthon55 and Li and colleagues56. Y15 and Y20 samples from the same participant 
were always plated on the same 96 well plate to avoid batch differences. Each sample was 
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assayed 3 times on 3 different days. Samples were assayed on duplicate wells, resulting in 6 
data points. Sample plates were assayed in groups of three plates, and no two plates were 
grouped together more than once to eliminate potential systemic plate-to-plate batch 
differences. Because degraded DNA have high T/S ratios (unpublished results, Blackburn 
lab), all samples with T/S greater than 1.5 were run on 0.8% agarose gels to assess whether 
the DNA is degraded. Of the 33 samples run, 10 samples were degraded. These samples 
were labeled as “DNA degraded” and excluded. In addition, samples with T/S below 0.5 
were also run on 0.8% gels. Of the 24 samples run, 4 samples were degraded and were 
labeled as “DNA degraded” and excluded. The coefficient of variation (CV) for each sample 
was calculated by dividing the standard deviation (SD) by the average of the six data points. 
The average CV for all the samples in this study is 3.5%±2.1%.
Telomere T/S ratio was converted to base pairs using the equation: Base Pair (TL) = 
3274+(2413*T/S)56. Following the conversion to base pairs, a 5-year TL change score was 
computed: TL change = Base pair TL Y20 – Base pair TL Y15. Negative values of TL 
change indicate attrition over the five-year period.
Covariates.—Covariates utilized for the present study were collected at Y15 and included: 
(1) Sociodemographic factors, (2) health risk, and (3) medical history.
Sociodemographic covariates included age, sex, race, education, and household income. 
Consistent with past research using the CARDIA study,52 a continuous distribution of 
household income was created by selecting the midpoint across nine income categories of 
specific ranges. This new continuous variable was cube-transformed to minimize skew and 
kurtosis.
Health risk included body mass index (BMI), alcohol use, and smoking history. BMI 
(weight/height2) was categorized as underweight (<18.5), normal (18.5–24.9), overweight 
(25.0–30.0) and obese (>30.0) Alcohol use was categorized as non-drinkers, moderate 
drinkers (women: 1–10 drinks/week; men: 1–15 drinks/week), and heavy drinkers (women 
>10 drinks/week; men >15 drinks/week). Smoking history categorized users as non-
smokers, current smokers, or past smokers. Medical history was a self-reported summed 
variable of twenty-one diagnosed chronic physical health conditions.
Statistical Analyses
Analyses were computed in SAS 9.4. Frequencies and descriptive statistics were probed. 
Following deletion of cases without telomere data, there were missing data on education 
(.1%), income (.7%), smoking history (.2%), BMI (.2%), and past illness history (4%). 
Participants missing past illness history (n = 41) had less education than those with past 
illness data (r = −.06, p =.05). Participants missing data on income (N = 7) were more likely 
to be male (r = .09, p = .004), be black (r = .10, p = .001), have lower education (r = −.10, 
p=.002). To handle the missing cases, we utilized multiple imputation and created 25 new 
datasets with Proc MI; results from the imputed datasets were then pooled with Proc 
MIanalyze57,58.
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The following analyses were completed for the study. Bivariate correlations between Y15 
and Y20 TL measures, chronic burden at Y15 and Y20, and multisystem resiliency and its 
components were examined. Next, we regressed TL change on chronic burden at Y15 
(Model A), without covariates or resiliency factors. Next, we regressed TL change on Y15 
chronic burden, and included sociodemographic factors as covariates (Model B). Model C 
included Model B and health risk factors. Model D included Model C and medical history, 
and Model E included Model D factors and the independent resiliency factors. We then 
completed three individual regression analyses that included an interaction term between 
chronic burden at Y15 and psychosocial resources, social connections, and health-
maintaining behaviors, while including the other two resiliency factors as covariates. Next, 
we repeated these sets of analyses whereby multisystem resiliency replaced the three 
individual resiliency factors, and completed a final regression that included the interaction 
between chronic burden at Y15 and multisystem resiliency. These analyses were repeated 
including the repeated chronic burden score (Y15+Y20) in lieu of the Y15 chronic burden 
score alone. The Benjamini-Hochberg false discovery adjustment59 was used to correct for 
multiple interaction analyses, with significant interaction terms probed. All decomposition 
models had acceptable multicollinearity diagnostics (VIF >10 and Tolerance <1).
Results
Descriptive and Bivariate Statistics.
At Y15, participants were, on average, 40.50 years old (SD = 3.51), white (59.55%), female 
(65.33%), and college educated (60.43%). Participants were predominantly overweight 
(35.47%) or obese (32.99%), were mostly non-smokers (62.36%), and moderate drinkers 
(63%). Forty-six percent (46.44%) of participants reported no somatic ailments, 43.32% 
reported 1–2 somatic ailments, and 10.24% reported 3+ somatic ailments. Table 1 displays 
full descriptives, and also by race and sex.
At Y15, mean TL was 5,582 base pairs (SD = 466.45). At 5-year follow-up, mean TL was 
5,674 base pairs (SD = 435.33). TL change over the 5 years was 92.64 (SD = 462.58, range 
−1566.90 to 1650.41), suggesting an average 18.5 base-pair increase in telomere length per 
year. Leukocyte telomere lengths at Y15 and Y20 were significantly positively associated (r 
= .48, p <.0001). Y15 TL was negatively associated with TL change (r = −.56, p < .0001). 
TL change did not differ as a function of sex (p =.66) or race (p =.24).
See Table 2 for correlations between each resiliency factor, multisystem resiliency, chronic 
burden at Y15 and Y20, and TL Y15, Y20 and change.
Direct Associations of Y15 Chronic Burden and Resiliency Factors with TL Change.
TL change was regressed on chronic burden at Y15, not including any covariates or 
resiliency factors, and estimates were not significant (B = −0.88, SE =12.59, .95 % CI = 
−25.59, 23.83, p = .94) (Table 3, Model A). In a final model (Table 3, Model E) adjusting for 
sociodemographic factors, health risks, and medical history, chronic burden at Y15 was not 
significantly associated with TL change (p = .81), nor were psychological resources (p 
= .15), social connections (p = .36), and health-maintaining behaviors (p = .40). In a separate 
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fully-adjusted model with individual resiliency factors removed and replaced with the 
combined multisystem resiliency (individual models not shown), multisystem resiliency was 
also not significantly related to TL change (B = −10.60, SE = 7.45, 95 % CI = −25.23, 4.03, 
p = .16).
Interactions Between Y15 Chronic Burden and Resiliency Factors with TL Change.
In separate analyses, the interaction between Y15 chronic burden with psychological 
resources (B = 9.54, SE = 4.78, 95% CI = 0.16, 18.92, p = .046) was significant, but not for 
social connections (B = 7.54, SE = 7.05, 95 % CI = 6.30, 21.37, p = .29) and health-
maintaining behaviors (B = 16.01, SE = 9.02, 95 % CI = −1.70, 33.71, p = .08). The 
interaction term for multisystem was significant (B = 10.43, SE = 5.28, 95% CI = 0.07, 
20.79, p = .048). However, when the Benjamini-Hochberg correction for the false discovery 
rate (FDR) is applied to these four completed interactions, no interaction remained 
significant.
Direct Associations of Repeated Chronic Burden (Y15+Y20) and Resiliency Factors with TL 
Change.
In a model without any covariates, repeated chronic burden was not associated with TL 
change (Table 4, Model A). Adjusting for all covariates (Table 4, Model E), repeated chronic 
burden was not significantly associated with TL change (p = .55), nor were psychological 
resources (p = .14), social connections (p = .32), and health-maintaining behaviors (p = .42). 
In a separate fully-adjusted model (individual models not shown), the combined multisystem 
resiliency score was not significantly related to TL change (B = −11.48, SE = 7.56, 95% CI 
= −26.37, 3.41, p = .13).
Interactions Between Repeated Chronic Burden (Y15+Y20) and Resiliency Factors with TL 
Change.
Interactions between repeated chronic burden with psychological resources (B = 7.85, SE = 
2.78, 95% CI = 2.40, 13.30, p = .005), social connections (B = 8.51, SE = 4.08, 95% CI = 
0.52, 16.51, p = .04), health-maintaining behaviors (B = 11.97, SE = 5.26, 95% CI = 1.64, 
22.29, p = .02) were all significant. The interaction between repeated chronic burden and 
multisystem resiliency was also significant (B = 8.82, SE = 3.01, 95% CI = 2.90, 14.73, p 
= .004). Accounting for the FDR for multiple testing, each resiliency factor significantly 
moderated the relationship between repeated chronic burden and telomere length change 
(Standardized β range 0.12 to 0.16; p’s < .05). Table 4 summarizes the simple slope analyses 
for the associations between Y15+20 chronic burden and TL change at the means of each 
resiliency factor examined, and at 1SD above and below the means. As seen in Table 5, at 
lower levels of multisystem resiliency, repeated chronic burden was significantly associated 
with accelerated telomere attrition, whereas unrelated to telomere attrition at mean or higher 
levels of resiliency. Similar trends in effects were observed for the three independent 
resiliency factors, but repeated chronic burden was only associated with significant telomere 
attrition at low levels of psychological resources.
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Follow-up analyses revealed that when sleep quality was substituted for average sleep hours 
per night, analyses yielded similar results. Additional follow-up analyses revealed that the 
effects presented were not modified by race.
Discussion
This study sought to examine the effects of chronic burden on telomere length change over 
time, and whether telomere change is different at different levels of psychosocial and 
behavioral resiliency factors. Results show that individuals with decrements of psychosocial 
and behavioral resiliency have significant declines in telomere length over five years that are 
directly associated with their repeated reports of chronic burden across multiple domains, 
whether examined prospectively or with repeated assessments at the 5 year intervals. The 
compounding effect between decrements of resiliency and chronic burden was especially 
robust when we examined repeated reports of chronic burden, as these effects remained 
significant after adjustment for the false discovery rate. Conversely, participant 5-year 
telomere length change was unrelated to their repeated reported chronic burden for those 
with average or higher resiliency. Findings were consistent whether psychosocial and 
behavioral factors were considered independently or combined into a multisystem resiliency 
factor. These findings are similar to previous cross-sectional studies indicating that 
behavioral and psychosocial factors combine to mitigate the association between chronic 
stress45 or depression50 and telomere length cross-sectionally and between psychosocial 
stressors and telomere attrition over a one-year period.39
Psychosocial, socioeconomic, and environmental stressors in adulthood and reports of 
chronic psychological stress have been implicated in accelerating systemic physiological 
deterioration among individuals, as discussed in the allostatic load model60 and weathering 
hypothesis.61 Elevated levels of the stress hormone, cortisol, have been associated with 
shorter telomeres,62,63 with some exceptions.64 Steptoe and colleagues65 have demonstrated 
that individuals who increased their cortisol levels by ≥20% in response to mental stress had 
shorter telomeres three years later, compared to those who did not have elevated cortisol 
levels, after covarying for sociodemographic and health factors. The current study 
considered a chronic difficulty as psychologically stressful only if participants reported that 
the stressors were at least moderately or very stressful. Similarly, daily stressors and their 
related changes in affective states are prospectively impactful on psychological66 and 
physical health67 and mortality68 in individuals who affectively react more to the stressors 
compared to those who react less. Taken together, these studies suggest that proximal 
affective, cognitive, and biological responses to stressors may have long-term effects on 
health outcomes and early mortality. However, future studies should clarify the independent 
roles of stressor exposure and the perceptions of stress in the face of these stressors on health 
and mortality, as has been proposed elsewhere.69
Our results indicate that these conclusions may be true, but perhaps only in those with 
insufficient resiliency, and only in those who report burden repeatedly. Here, only those 
participants with low levels of psychological and social resources and who were less likely 
to maintain healthful behaviors had significant telomeric attrition associated with chronic 
psychosocial and financial burden reported twice over a 5-year period. Psychosocial 
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resources and healthy behaviors have been proposed elsewhere as inoculating individuals to 
stress,42,47,70,71 suggesting that these factors act to mitigate or buffer against life stressors 
and lifespan adversity. However, psychosocial resources and engagement in more, compared 
to less, healthful behaviors emerge through the repeated experience with adversity across the 
lifespan, especially in childhood, as proposed by the environmental affordances model72 or 
biographical structuration,73 suggesting mediation. In the current study, it is not surprising 
then that chronic burden was negatively and significantly associated with resiliency factors, 
but these factors were not directly associated with telomere length change. Our study 
indicates that, even though those repeatedly reporting stressors as stressful are less likely to 
report having psychosocial resources and maintaining healthful behaviors, the interaction 
effects suggest that some participants were still resilient in the face of high stress 
perceptions, and that these resiliency factors mitigate telomere length change. Future studies 
are required that repeatedly assess psychosocial and financial stressors and assessments of 
social connections, psychological resources, and health-maintaining behaviors across the 
lifespan to disentangle who emerges resilient in the face of stressors and what environmental 
conditions allow for resiliency to develop.
The current study has several strengths. First, measures of chronic burden were evaluated at 
two consecutive time points separated by 5 years, used with corresponding leukocyte 
telomere lengths assayed from extracted DNA from stored frozen blood from Y15 and Y20 
of the CARDIA Study. Previous studies associating psychological stress or life stressors 
with telomere length were predominantly cross-sectional in nature70. Studies that have 
examined long-term effects of stress on telomere lengths have combined retrospective 
reports of lifespan stressors and associated them with a one-time measure of telomere 
length.37,38,74,75 Prior to the current study, only one study used two assessments of telomere 
length separated by one year to assess telomere attrition as it corresponds to cumulative 
exposure to psychosocial and financial stressors.39 To our knowledge, our study captures the 
longest period of time between two assessments of telomere length reported in a study 
examining the prospective relationship between chronic burden and 5-year change in 
telomere lengths and repeated experiences of chronic burden on accelerated telomere 
change. While studies with multiple time points are costlier and a greater burden on 
participants due to the requirement of their repeated participation in study protocols, they 
provide the opportunity to reveal associations between measures as real life circumstances 
unfold - associations that cross-sectional studies cannot uncover. Specifically, our study 
allowed for the discovery of temporal effects between stressful life experiences and 
resiliency factors, findings that can potentially inform future research and health programs 
directed to reducing the negative impact of chronic burden.
We next consider study limitations. First, and importantly, there was a slight average annual 
increase in telomere lengths by approximately 18 bp/year, a departure from some previous 
studies that indicate that telomere lengths shorten over time, on average. Some studies 
demonstrate that telomere length is dynamic, with the possibility of lengthening over time, 
though there is wide debate in the literature about whether telomeres can actually lengthen 
over time.76–78 In the CARDIA study, whole blood samples were collected with the same 
protocols and the same type of genomic DNA extraction kit was used to extract DNA, but 
different lots were used in both procedures. Telomere length assays for Y15 and Y20 DNA 
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were completed at the same time, with Y15 and Y20 samples from the same individual on 
the same plate, circumventing major criticisms suggesting serious measurement errors when 
telomere lengths are assayed at different times and on different plates.79 Previously reported 
results80,81 with the CARDIA study telomere data indicated that telomere lengths at Y15 
was significantly correlated to telomere lengths Y20 (r = 0.48, p < .001; reported here as 
well), and that associations between age, sex and race with telomere lengths at Y15 and Y20 
were similar, supporting validity of the values. However, average telomere length at Y15 was 
lower, suggesting steady DNA degradation. Pre-analytical factors (such as different lots of 
the blood collection tubes and DNA extraction kits) and length of time blood samples were 
stored in the freezer may have accounted for the slight upward tick in telomere length.
Second, our study is limited by the time points at which the resiliency factors were measured 
and their time frames. While physical activity, sleep and social connections were available 
for Y15 and Y20 of CARDIA (Y15 to Y20 r’s= .63, .35, .58 respectively, all p’s < .001), 
none of the psychological resources scales were included more than once, available only at 
Y15. Given the moderate to strong correlations between Y15 and Y20 for available data and 
in order to test a multisystem resiliency model that included psychological, behavioral and 
social components, as we and others have proposed elsewhere47,70, we designed our study 
using data available in CARDIA at Y15 to develop our resiliency measures. Subjective sleep 
and physical activity assessments were used to develop a health-maintaining behaviors 
measure and were measured on different time frames. Previous CARDIA82 research 
reported over-reporting of sleep duration through self-report when compared to sleep 
duration measured by actigraphy devices. Self-reported physical activity is also known to be 
over-reported in retrospective reports.83 Objective measures of either behavior were 
unavailable at Y15 and thus unavailable to test whether objective measures of health 
behaviors would display similar mitigating effects. Furthermore, dietary behaviors have also 
been evidenced to either mitigate39 or compound84 the effects of chronic stress on health 
outcomes. Health-maintaining behaviors naturally cluster85,86 and, in combination, are 
associated with longer telomeres than each behavior alone.87 Diet, physical activity and 
sleep quality combine to significantly mitigate telomere attrition in those reporting greater 
adversity over a one year period whereas each behavior alone only trended towards 
significance.39 Dietary patterns were unavailable at Y15.
Repeated psychosocial, work-related, and economic stressors that were experienced as 
stressful were related to accelerated telomere attrition over a 5-year period only in midlife 
adults who reported low levels of psychosocial and behavioral resiliency. These results add 
to a growing literature on both the health burden of long-term stress and the importance of 
maintaining healthy social connections, emotion regulation and behaviors as we age. 
Importantly, the current results suggest that future intervention and policy may benefit from 
identifying and targeting individuals with appraisal phenotypes most stress-susceptible and 
designing approaches to alter these appraisals, creating and promoting stable, social 
communities for vulnerable individuals, and developing community-based approaches to 
support healthy behavior engagement during times of stress.
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